August 8th 2025, 1:00pm
Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.
August 7th 2025, 9:00pm
I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.
August 7th 2025, 7:00pm
Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.
August 7th 2025, 5:00pm
I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.
August 7th 2025, 4:00pm
In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.
August 7th 2025, 3:00pm
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
August 7th 2025, 1:00pm
Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.
August 6th 2025, 9:00pm
Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.
August 6th 2025, 8:00pm
In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.
August 6th 2025, 6:55pm
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.
Sharing Stories of Survivorship
Perioperative Therapy in Resectable NSCLC: The Drive for a Cure
How My Daughter Stood Up to Breast Cancer
Test May Predict Breast Cancer Recurrence Risk, Chemotherapy Benefit